Post-Infectious Disorders: Clinical Trials

741 trials for Post-Infectious Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

326 completed, 141 unknown, 133 recruiting, 44 not yet recruiting. 315 Not applicable, 108 Phase 2, 45 Phase 3, 27 Phase 1, 11 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable315Completed 145, Recruiting 57, Unknown 56, Active not recruiting 19, Not yet recruiting 16, Withdrawn 8, Terminated 6, Enrolling by invitation 4, Suspended 4
Phase 2108Completed 54, Recruiting 16, Unknown 11, Not yet recruiting 9, Active not recruiting 8, Withdrawn 5, Terminated 3, Enrolling by invitation 2
Phase 345Completed 21, Recruiting 9, Unknown 6, Not yet recruiting 3, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1, Terminated 1
Phase 127Completed 13, Unknown 6, Recruiting 3, Not yet recruiting 2, Withdrawn 2, Terminated 1
Phase 411Unknown 4, Completed 3, Recruiting 2, Active not recruiting 1, Terminated 1
Early Phase 18Completed 2, Recruiting 2, Suspended 1, Terminated 1, Unknown 1, Withdrawn 1

Follow Post-Infectious Disorders: new trials by email Literature Review of Post-Infectious Disorders trials Research Report on Post-Infectious Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Taurine Supplementation in Adolescents With Post-COVID Condition
Taurine - Long COVID, Post COVID-19 Condition
Phase 1 / Phase 2Not yet recruitingUniversity of Alberta302026-12-302026-10-16
CD19-B Cell Depletion in PAIS-ME/CFS Patients
Inebilizumab, Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID 19 Condition (PCC or Long COVID)
Phase 2Not yet recruitingCharite University, Berlin, Germany382026-12-012026-07-24
A Study of Empasiprubart as Add-On Therapy to IVIg in Adult Participants With Guillain-Barré Syndrome
Empasiprubart IV, Empasiprubart Placebo IV, Intravenous immunoglobulin (IVIg) - Guillain-Barré Syndrome (GBS)
Phase 2Not yet recruitingargenx632026-12-012026-09-25
Fatigue in Long COVID
Lightning Process, Activity Pacing - Long COVID
Not applicableNot yet recruitingMcMaster University1002026-11-012026-07-13
The Precision Mito- Mito Map COMPASS Study
Mito Map Energy Score and Home Functional Assessments - Mitochondrial Diseases, Myalgic Encephalomyelitis Chronic Fatigue Syndrome
Not yet recruitingAI Agent Vault, Inc. d/b/a Precision Mito4002026-11-012026-10-02
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Keytruda - Post-Acute COVID-19 Syndrome
Phase 1Not yet recruitingNational Institute of Neurological Disorders and Stroke (NINDS)152026-10-272026-10-22
Peripheral Nerve Ultrasound in Children With Guillain-Barré Syndrome
Guillain-Barre Syndrome
Not yet recruitingAssiut University422026-10-102026-10-08
Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)
Aripiprazole (low-dose, 1mg), Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID-19 Condition (PCC or Long COVID)
Phase 2Not yet recruitingChristiana Franke1382026-10-012026-07-20
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
Cryotherapy - ME/CFS, Fibromyalgia (FM)
Not applicableNot yet recruitingOxford Brookes University402026-10-012026-10-14
Myocardial Changes in Pediatric Guillain-Barré Syndrome
Myocardial Dysfunction, Guillain-Barre Syndrome
Not yet recruitingAssiut University722026-09-262026-09-25
Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue
Transcranial Direct Current Stimulation - Long COVID, Post-COVID Conditions
Not applicableNot yet recruitingUniversity of Las Palmas de Gran Canaria202026-09-152026-07-22
Epigenetic Changes in Long COVID Patients
Long COVID-19 Syndrome, Long COVID Symptoms
Not yet recruitingIstituti Clinici Scientifici Maugeri SpA10002026-09-012026-08-11
Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barré Syndrome(GREAT)
Intravenous immunoglobulin (IVIG), Efgartigimod Alfa-Fcab - Guillain-Barré Syndrome
Phase 2Not yet recruitingBeijing Tiantan Hospital1102026-09-012026-09-18
Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC)
Post-Acute Sequelae of COVID-19 (PASC) Assessment - Long COVID, COVID-19
Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS9002026-09-012026-08-14
Micro-choice-based Intervention for Multicausal Fatigue
Micro-choice-based intervention - Multicausal Fatigue, Fatigue
Not applicableRecruitingUniversity Hospital, Basel, Switzerland242026-08-132026-08-18
Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism
Post-Acute Sequelae of SARS-CoV-2 Infection, Long COVID
Not yet recruitingTamara C Tamas502026-08-012025-12-02
Sauna for Long Covid
whole body hyperthermia - Long COVID
Not applicableRecruitingMassachusetts General Hospital212026-08-012025-11-13
Cognitive Impairment and Return to Work in Long COVID
Long COVID
CompletedHopitaux de Saint-Maurice552026-08-012026-10-19
A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID
Treatment A: Treatment by a homeopath prescribing a specific homeopathic remedy for long COVID, a course of individually tailored treatment by a homeopath - Long COVID, Long COVID Symptoms
Not applicableNot yet recruitingSt. Mary's University, Twickenham1202026-07-152026-07-09
A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID
Maraviroc (MVC), Atorvastatin, 10mg, 20mg, 40mg, Placebo, Maraviroc - Long COVID
Phase 2 / Phase 3Not yet recruitingHealthBio, Inc.2522026-07-152026-06-18

Showing 20 of 741. Sign in to see all of them.

Narrower conditions

Post-Acute COVID-19 Syndrome (597)  ·  COVID-19 (203)  ·  Guillain-Barre Syndrome (95)  ·  Fatigue (63)  ·  Fatigue Syndrome, Chronic (39)  ·  Motor Activity (29)  ·  Multiple Sclerosis (28)  ·  Mental Fatigue (27)  ·  Cognitive Dysfunction (24)  ·  Post-Lyme Disease Syndrome (22)  ·  Depression (21)  ·  Anxiety Disorders (18)  ·  Dyspnea (18)  ·  Postural Orthostatic Tachycardia Syndrome (17)  ·  Arthritis, Reactive (16)

Broader conditions

Disease Attributes (741)  ·  Pathologic Processes (741)  ·  Pathological Conditions, Signs and Symptoms (741)  ·  Chronic Disease (740)  ·  Infections (639)  ·  Respiratory Tract Diseases (602)  ·  Lung Diseases (601)  ·  RNA Virus Infections (600)  ·  Virus Diseases (600)  ·  Coronaviridae Infections (597)  ·  Nidovirales Infections (597)  ·  Pneumonia (597)  ·  Pneumonia, Viral (597)  ·  Respiratory Tract Infections (596)

Interventions

Exercise (13)  ·  Immunoglobulins, Intravenous (11)  ·  Rehabilitation (9)  ·  Educational Status (8)  ·  Plasmapheresis (8)  ·  Blood Specimen Collection (7)  ·  Acupuncture Therapy (6)  ·  Hyperbaric Oxygenation (6)  ·  Saline Solution (6)  ·  Surveys and Questionnaires (6)  ·  Transcranial Direct Current Stimulation (6)  ·  nirmatrelvir and ritonavir drug combination (6)  ·  Cognitive Training (5)  ·  Physical Therapy Modalities (5)  ·  Magnetic Resonance Spectroscopy (4)

Sponsors

Assiut University (15)  ·  Icahn School of Medicine at Mount Sinai (11)  ·  VA Office of Research and Development (11)  ·  Duke University (9)  ·  Charite University, Berlin, Germany (8)  ·  Columbia University (6)  ·  Johns Hopkins University (6)  ·  Karolinska Institutet (6)  ·  Kanecia Obie Zimmerman (5)  ·  Massachusetts General Hospital (5)  ·  Mayo Clinic (5)  ·  University of Alberta (5)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (4)  ·  Adhera Health, Inc. (4)  ·  Assistance Publique - Hôpitaux de Paris (4)

Countries

United States (234)  ·  Spain (53)  ·  Germany (46)  ·  Canada (43)  ·  United Kingdom (35)  ·  Italy (33)  ·  China (28)  ·  France (27)  ·  Brazil (22)  ·  Netherlands (18)  ·  Switzerland (17)  ·  Taiwan (16)  ·  Egypt (15)  ·  Austria (14)  ·  Turkey (Türkiye) (11)

Top investigators

Lucinda Bateman, MD (6)  ·  Brian A Fallon, MD (4)  ·  Avindra Nath, M.D. (3)  ·  Barry Make, MD (3)  ·  Christina Barkauskas, MD (3)  ·  Cyndya Shibao, MD (3)  ·  David Putrino, PT, PhD (3)  ·  Gary M Felker, MD (3)  ·  Janna Friedly, MD, MPH (3)  ·  Kanecia Zimmerman, MD PhD (3)  ·  Pam Taub, MD (3)  ·  Peter Novak, MD (3)  ·  Susan Redline, MD MPH (3)

Results publications

PMID 41720282, PMID 42282195, PMID 32784198, PMID 33428867, PMID 34273080, PMID 34308300, PMID 39356507, PMID 10377201, PMID 12668799, PMID 12973660, PMID 14715035, PMID 15023839, PMID 16267188, PMID 16271648, PMID 16314677, PMID 16831974, PMID 16849828, PMID 16900450, PMID 17786266, PMID 18258905, PMID 19248087, PMID 19568835, PMID 20155838, PMID 20498207, PMID 20590838, PMID 21622969, PMID 21745374, PMID 21885496, PMID 22003934, PMID 22067635, PMID 22100537, PMID 22168993, PMID 23568718, PMID 23572237, PMID 23875929, PMID 24012996, PMID 24790712, PMID 26320841, PMID 26928074, PMID 27572859, PMID 27694629, PMID 27705091, PMID 27856631, PMID 27993601, PMID 28106111, PMID 28168524, PMID 28406555, PMID 28975040, PMID 29034226, PMID 29128354

NIH funding

2025 (3), OT2HL156812 (3), 1OT2HL156812-01 (1), 2019 (1), 2023 (1), 272201800011C-P00005-9999-1 (1), 3UM1AI068614-14S1 (1), I01CX002668 (1), I01RX004572 (1), I21RX004092 (1), I21RX004409 (1), K08CA237619 (1), P30AG067988 (1), R01AG085873 (1), R01AG089307 (1)